Triple-negative breast cancer: Tumor metabolite aids cancer's escape from immune system

Cancer cell metabolism may play a key role in tumors' ability to evade the immune system. In a study published in the Journal for ImmunoTherapy of Cancer, researchers from GIGA demonstrate that methylglyoxal, a byproduct of tumor metabolism, contributes to the creation of an environment that favors the progression of triple-negative breast cancer and resistance to immunotherapy.

≈